Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Buy
4,275
+408
+11% +$87.8K 0.14% 45
2026
Q1
$841K Buy
3,867
+200
+5% +$44.4K 0.12% 44
2025
Q4
$838K Buy
3,667
+530
+17% +$121K 0.11% 38
2025
Q3
$726K Buy
3,137
+970
+45% +$198K 0.1% 44
2025
Q2
$402K Sell
2,167
-1,903
-47% -$354K 0.06% 55
2025
Q1
$853K Buy
4,070
+150
+4% +$29.2K 0.17% 29
2024
Q4
$697K Buy
3,920
+536
+16% +$98.5K 0.12% 38
2024
Q3
$580K Hold
3,384
0.11% 49
2024
Q2
$580K Buy
3,384
+12
+0.4% +$1.99K 0.11% 49
2024
Q1
$614K Sell
3,372
-400
-11% -$68.9K 0.13% 54
2023
Q4
$585K Buy
3,772
+80
+2% +$11.7K 0.16% 52
2023
Q3
$550K Buy
3,692
+2,337
+172% +$343K 0.18% 57
2023
Q2
$183K Sell
1,355
-95
-7% -$13.9K 0.06% 88
2023
Q1
$231K Sell
1,450
-400
-22% -$61.2K 0.09% 82
2022
Q4
$299K Buy
1,850
+400
+28% +$61.3K 0.13% 75
2022
Q3
$195K Buy
1,450
+200
+16% +$28.7K 0.08% 92
2022
Q2
$191K Sell
1,250
-500
-29% -$76.4K 0.08% 74
2022
Q1
$284K Buy
1,750
+500
+40% +$72.6K 0.08% 57
2021
Q4
$169K Hold
1,250
0.04% 63
2021
Q3
$135K Buy
1,250
+500
+67% +$57.1K 0.04% 70
2021
Q2
$84K Hold
750
0.02% 88
2021
Q1
$81K Hold
750
0.03% 89
2020
Q4
$80K Hold
750
0.03% 76
2020
Q3
$66K Sell
750
-500
-40% -$47.1K 0.03% 60
2020
Q2
$123K Buy
1,250
+900
+257% +$79.2K 0.06% 51
2020
Q1
$27K Hold
350
0.02% 65
2019
Q4
$31K Buy
+350
New +$29.1K 0.02% 94

Other funds holding ABBV

Hoey Investments's ABBV Position: Q2 2026 in Review

Hoey Investments increased its AbbVie (ABBV) stake by 11% in Q2 2026, buying an estimated $87.8K and bringing the position to 4,275 shares worth $1.08M. The position accounts for 0.14% of the portfolio, ranked #45.

Hoey Investments first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 2,132 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Hoey Investments held 4,275 shares of AbbVie worth $1.08M as of Q2 2026.
  • Hoey Investments bought 408 AbbVie shares in Q2 2026, an estimated $87.8K.
  • AbbVie made up 0.14% of Hoey Investments's portfolio in Q2 2026, its #45 holding.
  • Hoey Investments first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 2,132 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hoey Investments's 13F filing for Q2 2026, filed 27 Jul 2026.